|
|
Docu-menta >
Buscar por Autor Rio, P
Mostrando resultados 1 a 11 de 11
| Fecha de publicación | Título | Autor(es) | | 12-nov-2022 | Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells | Siegner, SM; Ugalde, L; Clemens, A; Garcia-Garcia, L; Bueren, JA; Rio, P; Karasu, ME; Corn, JE |
| ene-2020 | Advances in the gene therapy of monogenic blood cell diseases | Bueren, J; Quintana-Bustamante, O; Almarza, E; Navarro, S; Rio, P; Segovia, JC; Guenechea, G |
| jun-2025 | Gene therapy could correct blood stem cells inside, rather than outside, the body | Milani, M; Rio, P |
| 1-oct-2023 | Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia | Lasaga, M; Rio, P; Vilas-Zornoza, A; Planell, N; Navarro, S; Alignani, D; Fernández-Varas, B; Mouzo, D; Zubicaray, J |
| feb-2014 | Generation of iPSCs from Genetically Corrected Brca2 Hypomorphic Cells: Implications in Cell Reprogramming and Stem Cell Therapy | Navarro, S; Moleiro, V; Molina-Estevez, FJ; Lozano, ML; Chinchon, R; Almarza, E; Quintana-Bustamante, O; Mostoslavsky, G; Maetzig, T; Galla, M; Heinz, N; Schiedlmeier, B; Torres, Y; Modlich, U; Samper, E; Rio, P; Segovia, JC; Raya, A; Güenechea, G; Izpisua-Belmonte, JC; Bueren, JA |
| dic-2024 | Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials. | Rio, P; Zubicaray, J; Navarro, S; Gálvez, E; Sánchez-Domínguez, R; Nicoletti, E; Sebastián, E |
| 2021 | NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma | Leivas, A; Valeri, A; Cordoba, L; Garcia-Ortiz, A; Ortiz, A; Sánchez-Vega, L; Grana-Castro, O; Fernandez, L; Carreno-Tarragona, G; Perez, M; Megias, D; Paciello, ML; Sánchez-Pina, J; Perez-Martinez, A; Lee, DA; Powell Jr, DJ; Rio, P; Martinez-Lopez, J |
| sep-2025 | Regulatory Strategies for Accelerating the Translation of Gene Therapies to Clinical Practice: Focus on GMO Considerations | Delgadillo, J; Martín, F; Carmona, G; Canals, JM; Rio, P; Eguizabal, C; Prosper, F |
| sep-2019 | Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia | Rio, P; Navarro, S; Wang, W; Sánchez-Domínguez, R; Pujol, RM; Segovia, JC; Bogliolo, M; Merino, E; Wu, N |
| 6-abr-2014 | Targeted gene therapy and cell reprogramming in Fanconi anemia | Rio, P; Baños, R; Lombardo, A; Quintana-Bustamante, O; Alvarez, L; Garate, Z; Genovese, P; Almarza, E; Valeri, A; Díez, B; Navarro, S; Torres, Y; Trujillo, JP; Murillas, R; Segovia, JC; Samper, E; Surralles, J; Gregory, PD; Holmes, MC; Naldini, L; Bueren, JA |
| 2022 | Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia | Casado, JA; Valeri, A; Sanchez-Dominguez, R; Vela, P; Lopez, A; Navarro, S; Alberquilla, O; Hanenberg, H; Pujol, R; Segovia, JC; Minguillón, R; Surrallés, J; Díaz de Heredia, C; Sevilla, J; Rio, P; Bueren, JA |
Mostrando resultados 1 a 11 de 11
|
